Difference between revisions of "Part:BBa K3994010"
Line 3: | Line 3: | ||
<partinfo>BBa_K3994010 short</partinfo> | <partinfo>BBa_K3994010 short</partinfo> | ||
− | PhrpL_amilGFP_IL10_PJ23104_ttrS | + | |
+ | promoter | ||
+ | |||
+ | === Profile === | ||
+ | |||
+ | ==== Name: PhrpL_amilGFP_IL10_PJ23104_ttrS ==== | ||
+ | ==== Base Pairs: 4231 bp ==== | ||
+ | ==== Origin: Synthetic ==== | ||
+ | ==== Properties: A coding sequence of amilGFP and IL10 protein. ==== | ||
+ | |||
+ | === Usage and Biology === | ||
+ | |||
+ | ====Background==== | ||
+ | |||
+ | nflammatory bowel disease (IBD) is a chronic intestinal inflammatory disease of unknown etiology, including ulcerative colitis (CD) and Crohn’s disease (CD). This chronic disease, which is prone to repeated deterioration, currently lacks unified diagnostic and treatment standards, and is posing a great threat to public health. Drug therapy (anti-inflammatory drugs) is the preferred treatment for IBD. However, studies in the past 10 years have found that 30-50% of IBD patients do not respond to anti-TNF treatment. In addition, after long-term use of anti-inflammatory drugs, the patient's intestinal microbial status changes over time, and the effect may be lost due to drug resistance. Therefore, we need to seek help from other treatments for IBD. | ||
+ | |||
+ | === Construct design === | ||
+ | |||
+ | This part is a coding sequence of amilGFP and IL10. amilGFP is a fluorescent protein. IL10 is an anti-inflammatory factor. These two factors were under PhrpL promoter. And this part is inserted into plasmid. | ||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994010-Figure1.png|500px|thumb|center|Figure 1. PhrpL_amilGFP_IL10_PJ23104_ttrS box...]] | ||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994010-Figure2.png|500px|thumb|center|Figure 2. The sequence map of PhrpL_amilGFP_IL10_PJ23104_ttrS...]] | ||
+ | |||
+ | === BBa_K3994005 === | ||
+ | |||
+ | ==== Name: PhrpL ==== | ||
+ | ==== Base Pairs: 190bp ==== | ||
+ | ==== Origin: Synthetic ==== | ||
+ | ==== Properties: A coding sequence of promoter hrpL. ==== | ||
+ | |||
+ | === Usage and Biology === | ||
+ | |||
+ | It is the sequence of inducible promoter PhrpL. HrpR protein binds to HrpS protein forming a complex and then triggering the transcription of induced promoter PhrpL. It functions like a AND logic gate to open a gene circuit. The hrpL promoter (PhrpL) contains a functional UAS relative to the transcription start-site, to which purified HrpR, HrpS and HrpRS bind in electrophoretic mobility shift assays. | ||
+ | |||
+ | === BBa_K3994006 === | ||
+ | |||
+ | ==== Name: IL10 ==== | ||
+ | ==== Base Pairs: 864bp ==== | ||
+ | ==== Origin: Homo sapiens, genome ==== | ||
+ | ==== Properties: A coding sequence of an immune regulatory cytokine ==== | ||
+ | |||
+ | === Usage and Biology === | ||
+ | |||
+ | This is a coding sequence of IL10. This is a major immune regulatory cytokine that acts on many cells of the immune system where it has profound anti-inflammatory functions, limiting excessive tissue disruption caused by inflammation. | ||
+ | |||
+ | === Proof of function === | ||
+ | |||
+ | |||
+ | ==== Attempt 1 ==== | ||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994010-Figure3.jpg|500px|thumb|center|Figure 3 Genetic Construction of IBD Distinguisher...]] | ||
+ | |||
+ | |||
+ | Sample 1: NO3- + S4O62- | ||
+ | |||
+ | Sample 2: S4O62- | ||
+ | |||
+ | Sample 3: NO3- | ||
+ | |||
+ | Sample 4: Blank Control | ||
+ | |||
+ | |||
+ | |||
+ | As shown above, there is obvious fluorescence in sample 1 and sample 2; for sample 3 and sample 4, there also a slight fluorescence produced in the tubes. In order to scientifically quantify the result, we used ELIASA to read the accurate fluorescence intensity, respectively. | ||
+ | |||
+ | [[File:T--NOFLS YZ--BBa K3994010-Figure3.jpg|500px|thumb|center|Figure 3 Genetic Construction of IBD Distinguisher...]] | ||
+ | |||
+ | |||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Revision as of 10:52, 19 October 2021
PhrpL_amilGFP_IL10_PJ23104_ttrS
promoter
Profile
Name: PhrpL_amilGFP_IL10_PJ23104_ttrS
Base Pairs: 4231 bp
Origin: Synthetic
Properties: A coding sequence of amilGFP and IL10 protein.
Usage and Biology
Background
nflammatory bowel disease (IBD) is a chronic intestinal inflammatory disease of unknown etiology, including ulcerative colitis (CD) and Crohn’s disease (CD). This chronic disease, which is prone to repeated deterioration, currently lacks unified diagnostic and treatment standards, and is posing a great threat to public health. Drug therapy (anti-inflammatory drugs) is the preferred treatment for IBD. However, studies in the past 10 years have found that 30-50% of IBD patients do not respond to anti-TNF treatment. In addition, after long-term use of anti-inflammatory drugs, the patient's intestinal microbial status changes over time, and the effect may be lost due to drug resistance. Therefore, we need to seek help from other treatments for IBD.
Construct design
This part is a coding sequence of amilGFP and IL10. amilGFP is a fluorescent protein. IL10 is an anti-inflammatory factor. These two factors were under PhrpL promoter. And this part is inserted into plasmid.
BBa_K3994005
Name: PhrpL
Base Pairs: 190bp
Origin: Synthetic
Properties: A coding sequence of promoter hrpL.
Usage and Biology
It is the sequence of inducible promoter PhrpL. HrpR protein binds to HrpS protein forming a complex and then triggering the transcription of induced promoter PhrpL. It functions like a AND logic gate to open a gene circuit. The hrpL promoter (PhrpL) contains a functional UAS relative to the transcription start-site, to which purified HrpR, HrpS and HrpRS bind in electrophoretic mobility shift assays.
BBa_K3994006
Name: IL10
Base Pairs: 864bp
Origin: Homo sapiens, genome
Properties: A coding sequence of an immune regulatory cytokine
Usage and Biology
This is a coding sequence of IL10. This is a major immune regulatory cytokine that acts on many cells of the immune system where it has profound anti-inflammatory functions, limiting excessive tissue disruption caused by inflammation.
Proof of function
Attempt 1
Sample 1: NO3- + S4O62-
Sample 2: S4O62-
Sample 3: NO3-
Sample 4: Blank Control
As shown above, there is obvious fluorescence in sample 1 and sample 2; for sample 3 and sample 4, there also a slight fluorescence produced in the tubes. In order to scientifically quantify the result, we used ELIASA to read the accurate fluorescence intensity, respectively.
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal XbaI site found at 25
Illegal XbaI site found at 175
Illegal PstI site found at 13 - 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 2233
Illegal NheI site found at 2256
Illegal PstI site found at 13 - 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 31
- 23INCOMPATIBLE WITH RFC[23]Illegal XbaI site found at 25
Illegal XbaI site found at 175
Illegal PstI site found at 13 - 25INCOMPATIBLE WITH RFC[25]Illegal XbaI site found at 25
Illegal XbaI site found at 175
Illegal PstI site found at 13
Illegal AgeI site found at 379 - 1000COMPATIBLE WITH RFC[1000]